Oncology is undergoing a profound transformation, and this video series explores how innovation, precision medicine, evolving care networks, lifecycle strategy, and policy pressures are reshaping the path to sustainable impact. From the rise of biomarker‑driven segmentation to the growing importance of execution, evidence, and coordinated access planning, each feature highlights the forces redefining how therapies succeed in an increasingly competitive and complex environment. Together, these insights reveal why the future of oncology leadership depends on mastering not just scientific breakthroughs but the systems that bring them to life. Watch the full video series to see how these trends will shape the next era of oncology advancement.
Feature 1: Breast Cancer Innovation Evolution
Breast cancer illustrates oncology’s shift from breakthrough-driven innovation to execution-led success. As treatment pathways become longer and more complex, sequencing, biomarker identification, and sustained disease management define outcomes. Advances such as ADCs and expanded HER2 classifications are reshaping the market, but inconsistent testing limits uptake, making execution variability a critical constraint on realizing innovation’s full value.
Speaker: Anika LaFazia, Consultant, U.S. Thought Leadership & Innovation, IQVIA
Feature 2: Precision Medicine Reshapes Markets
Precision medicine is driving a structural shift in oncology, fragmenting markets into smaller biomarker-defined segments. While targeted therapies offer clearer efficacy and stronger outcomes, success increasingly depends on identifying eligible patients. Diagnostic variability and under-testing cap adoption, creating a strategic imperative to integrate diagnostics, evidence generation, and access early to scale beyond niche populations.
Speaker: Khushboo Rastogi, PhD, Sr. Consultant, Strategy and Consulting, IQVIA
Feature 3: NAS Growth and Investment
Oncology innovation is accelerating, but long-term value is no longer defined by launch alone. With rising NAS volume and sustained investment, success depends on lifecycle strategy, including follow-on indications, line expansion, and continuous evidence generation. Organizations that treat assets as evolving platforms, rather than one-time launches, are best positioned to capture durable growth in an increasingly competitive landscape.
Speaker: Durgesh Soni, Principal, Strategy and Consulting, IQVIA
Feature 4: Oncology Care Setting Shift
Oncology care delivery is shifting as consolidation drives the rise of large, community-based networks. These systems are expanding capabilities, managing more complex patients in-house, and retaining referrals within integrated networks. As referral pathways evolve, life sciences companies must adopt a network-centric engagement model that reflects how patient flow and decision-making are increasingly coordinated across interconnected systems.
Speaker: Luke Greenwalt, VP and Lead, U.S. Thought Leadership & Innovation, IQVIA
Feature 5: Execution Defines Oncology Leaders
In today’s oncology landscape, strong science is table stakes, while execution determines leadership. Increasing competition across similar targets and tumor types has shifted value creation toward sequencing, combination strategies, and lifecycle expansion. Early positioning and coordinated clinical, access, and commercial planning are essential, as long-term success is increasingly defined by how effectively assets are developed and scaled post-launch.
Speaker: Robert Steen, Sr. Principal, Insights and Analytics, IQVIA
Feature 6: IRA Reshapes Oncology
The Inflation Reduction Act is introducing earlier and more sustained pricing pressure in oncology, fundamentally altering the value lifecycle of leading brands. With multi-stage erosion now beginning before loss of exclusivity, companies must align evidence, positioning, and access strategies earlier. Success increasingly depends on proactive planning to sustain value under heightened regulatory and pricing scrutiny.
Speaker: Luke Greenwalt, VP and Lead, U.S. Thought Leadership & Innovation, IQVIA
Related solutions
Data, AI, and expertise empower Commercial Solutions to optimize strategy, accelerate market access, and maximize brand performance.
Grow your brand, now and through patent expiry
Gain high value access and increase the profitability of your brands